Evidera
- Company typePrivate
- Founded1984
- HeadquartersBethesda, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
Evidera firmographics
Firmographics- Name
- Evidera
- Legal name
- Evidera
- Website
- https://evidera.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Evidera industry classification
Industry- Product category
- Healthcare Real-World Evidence Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
Keywords
Where Evidera is headquartered
LocationHeadquarters
- HQ city
- Bethesda
- HQ country
- United States
- HQ region
- North America
Markets served
Evidera business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Research Services: Professional services revenue model providing real-world evidence solutions, observational studies, and consulting services to pharmaceutical and biotech companies throughout the product lifecycle from early development through post-market.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Evidera product offering
Product offeringCore offering
Evidera is a healthcare research company that generates real-world evidence (RWE) and health economics insights for the life sciences industry. The firm designs and executes observational studies, patient-centered research, health economics analyses, market access solutions, and clinical registries that inform drug development, regulatory, and reimbursement decisions. Evidera operates as part of PPD, the clinical research business of Thermo Fisher Scientific, and serves pharmaceutical, biotechnology, government, HTA, and payor clients.
Product overview
Evidera, operating as PPD Evidera within Thermo Fisher Scientific's PPD clinical research business, offers a unified platform of real-world evidence solutions. The core PPD Evidera Real-World Evidence service integrates proprietary PPD CorEvitas Clinical Registries for regulatory-grade longitudinal data, supplemented by specialized sub-products including Observational Studies, Patient-Centered Research, Implementation Science, Real-World Data and Scientific Solutions, Pregnancy and Lactation Studies, and Health Economics & Market Access services. Together, these products enable evidence generation across the entire drug development lifecycle from early discovery through post-market surveillance, serving biopharmaceutical companies, government agencies, HTA bodies, and payors.
Differentiator
Problem solved
Functional benefit
Brands
- PPD Evidera Patient-Centered Research: Patient-centered research services focusing on engaging patients throughout the drug development process
- PPD Evidera Implementation Science
- PPD Evidera Health Economics
- PPD Evidera Market Access
Products and services
- PPD Evidera Real-World Evidence Real-world evidence generation services that use observational data to support clinical, regulatory, and commercial decision-making for life sciences clients.
- Observational Studies Design and execution of observational research studies to evaluate treatment outcomes, safety, and effectiveness in real-world clinical settings.
- Real-World Data and Scientific Solutions Analytical and scientific services built around real-world data assets to address evidence gaps for pharmaceutical and biotech sponsors.
- PPD Evidera Patient-Centered Research Patient-centered outcomes research that captures the patient experience, including patient-reported outcomes, quality of life, and preference studies.
- PPD Evidera Implementation Science Implementation science services that help sponsors translate clinical evidence into routine clinical practice and measurable health system outcomes.
- PPD CorEvitas Clinical Registries Prospective clinical registries that collect longitudinal real-world data on disease cohorts and treatment patterns to support evidence generation.
- PPD CorEvitas Precision Medicine Precision medicine registry and analytics services that link molecular and clinical data to support targeted therapy evidence generation.
- PPD Evidera Health Economics Health economics and outcomes research (HEOR) services, including economic modeling, burden-of-illness, and cost-effectiveness analyses for sponsors.
- PPD Evidera Market Access Market access services that develop evidence dossiers and value communications to support payer, HTA, and reimbursement decision-making.
- Pregnancy and Lactation Studies Dedicated real-world research programs that generate safety and outcome data on medication use during pregnancy and lactation.
Quantifiable outcome
- Real-world evidence complements clinical trial data by providing broader patient representation and real-world context for more accurate assessment of comparative effectiveness and safety outcomes
- +1 more outcomes
Companies that use Evidera
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Evidera technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Evidera partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Thermo Fisher ScientificcoreEvidera is part of PPD, which is the clinical research business of Thermo Fisher Scientific. This ownership provides Evidera with substantial resources, global infrastructure, and integration with Thermo Fisher's broader laboratory and clinical research services.
Scale indicators1 record
Recent moves6 records
Expansion highlights6 records
Evidera competitors and assessment
Company assessmentDirect peers
- Parexel International: Global CRO with a dedicated real-world evidence and market access practice serving pharma and biotech across the product lifecycle. Competes with Evidera for observational studies, HEOR, and HTA submissions.
- IQVIA: Largest global CRO with an extensive real-world evidence, HEOR, and epidemiology practice built around linked patient data assets. Directly competes with Evidera for RWE, observational study, and market access engagements with biopharma.
- ICON plc: Top-five global CRO offering RWE, HEOR, outcomes research, and patient-centered solutions following its PRA Health Sciences and Symphony Health acquisitions. Competes head-to-head with Evidera on enterprise pharma RWE contracts.
- Syneos Health: Clinical and commercial services provider with real-world evidence, HEOR, and market access capabilities. Targets the same biopharma buyers as Evidera for late-phase and post-launch evidence generation.
Broad incumbents
- Oracle Health Sciences (formerly Cerner Enviza): Broader clinical research and real-world data platform within Oracle's health portfolio, providing EDC-adjacent RWE infrastructure. Overlaps with Evidera on real-world data analytics and study delivery at biopharma clients.
- Medidata Solutions (Dassault Systèmes): Clinical trial technology platform within Dassault Systèmes with real-world evidence and synthetic control arm capabilities. Competes partially with Evidera where sponsors prefer integrated software plus services for RWE generation.
Emerging players
- Veradigm (Allscripts): Real-world data and analytics provider built on ambulatory EHR data, supplying de-identified datasets and analytics for biopharma. Competes with Evidera on the upstream real-world data asset layer feeding RWE studies.
- Flatiron Health: Roche-owned real-world evidence provider focused on oncology EHR-derived datasets and point-of-care evidence generation. An emerging specialist competitor to Evidera's registry model in oncology and rare-disease RWE.
- TriNetX: Global health research network enabling protocol design, cohort feasibility, and real-world evidence on federated EHR data. Competes with Evidera on observational study design and rapid-cycle real-world analytics.
- Aetion: Real-world evidence analytics platform used for regulatory-grade outcomes and safety studies. An emerging specialist competitor to Evidera's RWD analytics and HEOR offerings, especially for payer and regulatory submissions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Evidera social profiles
Digital presenceEvidera financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evidera leadership team
Management profileNumber of profiles
Profiles5 records
Evidera funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evidera M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evidera
What does Evidera do?
Evidera is a healthcare research company that generates real-world evidence (RWE) and health economics insights for the life sciences industry. The firm designs and executes observational studies, patient-centered research, health economics analyses, market access solutions, and clinical registries that inform drug development, regulatory, and reimbursement decisions. Evidera operates as part of PPD, the clinical research business of Thermo Fisher Scientific, and serves pharmaceutical, biotechnology, government, HTA, and payor clients.
Is Evidera a public or private company?
Evidera is a private company. It is classified as corporate owned and is currently operating.
When was Evidera founded?
Evidera was founded in 1984. It employs 501 to 1,000 people.
Where is Evidera based?
Evidera is headquartered in Bethesda, United States, in the North America region.
How does Evidera make money?
One revenue line is on record: clinical Research Services.
Who are Evidera's main competitors?
Direct peers on record are Parexel International, IQVIA, ICON plc and Syneos Health. Broad incumbents are Oracle Health Sciences (formerly Cerner Enviza) and Medidata Solutions (Dassault Systèmes). Emerging players are Veradigm (Allscripts), Flatiron Health, TriNetX and Aetion.
Does Evidera have an API?
No public API is recorded for Evidera.
What industry is Evidera in?
Evidera's product category is Healthcare Real-World Evidence Research. Its primary akta.pro industry code is HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs, with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 541714 and its SIC code is 8731.